Elektrofi
Business Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
25 Drydock Ave, Boston, Massachusetts, 0...Phone Number
(866) 610-2683Website
www.elektrofi.comRevenue
$14.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Elektrofi
Elektrofi, Inc. is a biotechnology and biopharmaceutical formulation technology company focused on transforming the administration and delivery of biologic medicines. The company develops advanced formulation technologies that enable biologic therapies to be administered subcutaneously rather than through conventional intravenous infusion methods. By concentrating on improving patient accessibility, convenience, and treatment flexibility, Elektrofi aims to redefine how complex biologic medicines are delivered across healthcare systems worldwide. The organization was established by a group of scientists, engineers, and biotechnology innovators with expertise spanning fluid mechanics, pharmaceutical science, protein formulation, microsystems engineering, and biologic drug delivery. The companys leadership and scientific foundation emerged from advanced academic and research environments, particularly from technology and engineering disciplines associated with scientific innovation in bioRead more
Elektrofi Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Elektrofi your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Elektrofi has recently received funding, and reach out quickly before it becomes old news!
Click to see if Elektrofi had a recent Job posting/layoffs
Check out if Elektrofi is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Elektrofi
Elektrofi, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Elektrofi recently announced quarterly report
Product Launch: Get notified when Elektrofi launches new products
Funding: Get notified immidiatlly once Elektrofi has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Elektrofi as Masked Content
Find more new buyers
Compare Similar Companies to Elektrofi
Compare insights from companies similar to Elektrofi, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Elektrofi is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Elektrofi is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Elektrofi.
Elektrofi financials insights
Gather financial insights about Elektrofi, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2021
Debt
$332K
2022
Series B
$40M
2024
Series C
$112.3M
Elektrofi Tech Stack
A closer look at the technologies used by Elektrofi
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Elektrofi News & Media
Halozyme Completes Acquisition of Elektrofi, Expanding Breadth of Offerings in Drug Delivery
Royalty revenue contribution expected to begin as early as 2030 Initial partner targets include derisked MoAs that are approved blockbusters today Highly scalable licensing model and long duration IP into 2040s; potential for individual product IP extension through proprietary...Halozyme eyes microparticles in $900m Elektrofi acquisition - Pharmaceutical Technology
Halozyme Therapeutics has agreed to acquire US-based Elektrofi in a deal worth up to $900m, adding microparticle capabilities to its portfolio of drug delivery technologies.Halozyme Therapeutics, Inc. (HALO) Discusses To Acquire Elektrofi Conference Call (Transcript)
Halozyme acquires Elektrofi to boost drug delivery tech, expanding at-homeElektrofi Announces Oversubscribed $112.25 Million Series C Financing to Establish ...
Elektrofi, Inc., a biopharmaceutical delivery technology company focused on improving the patient experience and expanding access to life-changing medicines through the freedom of self-administration, today announced the closing of an upsized and oversubscribed $112.25M Series C financing. The financing was co-led by Novo Holdings, RA Capital Management, Royalty Pharma, SR One, and TPG Life Sciences Innovations, with participation from Eli Lilly and Company. Other premier new and existing life s
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Elektrofi
Sign Up For FreeTo access detailed company insights
Elektrofi, Inc. is a biotechnology and biopharmaceutical formulation technology company focused on transforming the administration and delivery of biologic medicines. The company develops advanced formulation technologies that enable biologic therapies to be administered subcutaneously rather than through conventional intravenous infusion methods.... Read More
